ATC code None PubChem CID 44557636 3D model (Jmol) Interactive image Molar mass 265.285 g/mol | CAS Number 872363-17-2 ChemSpider 25069676 Formula C16H12FN3 | |
 | ||
Dipraglurant (INN) (code name ADX-48621) is a negative allosteric modulator of the mGlu5 receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it is in phase II clinical trials for this indication. Addex Therapeutics is also investigating an extended-release formulation of dipraglurant for the treatment of non-parkinsonian dystonia.
References
Dipraglurant Wikipedia(Text) CC BY-SA